NEW YORK (GenomeWeb News) – Orchid Cellmark’s third-quarter revenues declined around 4 percent year over year due to lower service revenues in the UK.
 
The Princeton, NJ-based DNA testing services firm reported revenues of $14.9 million for the three-month period ended Sept. 30, compared with revenues of $15.6 million in the comparable period of 2007. A decline in UK revenues was partially offset by a 4 percent increase in US revenues during the quarter, the firm said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.